June 11, 2025 8-Week Oral Therapy Approved for Acute HCV The FDA has approved Mavyret for the treatment of acute hepatitis C, offering physicians a pangenotypic, 8-week oral regimen for early intervention. Conexiant
June 11, 2025 Evolving Role of Surgical De-escalation for Endometrial, Ovarian, Cervical, and Vulvar Cancers The ASCO Post
June 11, 2025 Spectroscopy Research Roundup: Handheld insights from Palace to Pregnancy The Analytical Scientist
Trends in the Prevalence of Hepatitis C Infection During Pregnancy and Maternal-Infant Outcomes in the U.S., 1998 to 2018
June 11, 2025 Evolving Role of Surgical De-escalation for Endometrial, Ovarian, Cervical, and Vulvar Cancers The ASCO Post
May 09, 2025 Study Shows Disparities in Diagnosing Endometrial Cancer in Women With Postmenopausal Bleeding The ASCO Post
April 24, 2025 Pembrolizumab Plus Chemotherapy: New Standard of Care in Locally Advanced Cervical Cancer? The ASCO Post
March 29, 2023 TTUHSC El Paso Hunt School of Dental Medicine Receives $10,000 Gift from Trellis Company Inside Dentistry